Login:
 
Naltrexone lowers hospital admissions in alcohol use disorder. Practitioner October 2021;265(1852):7-9

Naltrexone lowers hospital admissions in alcohol use disorder

27 Oct 2021Registered users

The risk of hospitalisation for an alcohol-related or other cause is lower when patients with alcohol use disorder are treated with naltrexone alone or in combination with disulfiram or acamprosate, a nationwide Swedish study has found. However, acamprosate monotherapy was associated with an increased risk of hospital admission for an alcohol-related cause.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.

To buy this article (£25+tax) copy the article citation above and click Buy article